PANZA, SALVATORE
 Distribuzione geografica
Continente #
AS - Asia 150
EU - Europa 115
NA - Nord America 74
SA - Sud America 22
AF - Africa 3
Totale 364
Nazione #
SG - Singapore 128
US - Stati Uniti d'America 67
DE - Germania 40
IT - Italia 25
FI - Finlandia 24
BR - Brasile 19
HK - Hong Kong 10
NL - Olanda 8
AT - Austria 6
GB - Regno Unito 4
MX - Messico 4
BD - Bangladesh 3
CA - Canada 3
ES - Italia 3
JP - Giappone 2
SE - Svezia 2
TR - Turchia 2
VN - Vietnam 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AR - Argentina 1
CL - Cile 1
CZ - Repubblica Ceca 1
DZ - Algeria 1
IE - Irlanda 1
IN - India 1
KE - Kenya 1
PY - Paraguay 1
SA - Arabia Saudita 1
ZA - Sudafrica 1
Totale 364
Città #
Singapore 82
Munich 33
Turku 24
Hong Kong 10
Naples 7
Nuremberg 7
Ashburn 5
Santa Clara 5
Seattle 5
Brooklyn 4
Mexico City 4
Chicago 3
Montreal 3
São Paulo 3
The Dalles 3
Vienna 3
Afragola 2
Belo Horizonte 2
Carney 2
Los Angeles 2
New York 2
San Francisco 2
Stockholm 2
Ahmedabad 1
Aracaju 1
Atlanta 1
Aversa 1
Bismarck 1
Boa Esperança 1
Boston 1
Buffalo 1
Cachoeirinha 1
Chittagong 1
Ciudad del Este 1
Constantine 1
Conyers 1
Dallas 1
Denbigh 1
Dhaka 1
Dublin 1
Fier 1
Gilmer 1
Goiânia 1
Haiphong 1
Haymarket 1
Ho Chi Minh City 1
Itabuna 1
Jeddah 1
Johannesburg 1
Kilis 1
Lawrence 1
London 1
Manassas 1
Montes Claros 1
Nairobi 1
Narsingdi 1
Natal 1
Nova Friburgo 1
Olomouc 1
Olta 1
Ourinhos 1
Phoenix 1
Pindamonhangaba 1
Porto Alegre 1
Princeton 1
Rende 1
Rome 1
Saginaw 1
San Jose 1
Santa Cruz do Sul 1
Sorrento 1
São Benedito 1
São Bento do Sul 1
Tokyo 1
Totale 266
Nome #
Assessing effectiveness of multistage nanomedicines for multidrug therapy of vitiligo 33
. Estrogen Receptor-Positive Breast Cancer Cells Drive CAFs to Secrete Leptin and Support Tumor Invasiveness 14
Expression and Subcellular Localization of Retinoic Acid Receptor alpha (RARα) in Healthy and Varicocele Human Spermatozoa: Its Possible Regulatory Role in Capacitation and Survival. 2015, WOS:000354886100008;2-s2.0-84930195711;PMID: 24992177 13
Evidence that CRISPR-Cas9 Y537S-mutant expressing breast cancer cells activate Yes-associated protein 1 to driving the conversion of normal fibroblasts into cancer-associated fibroblasts 13
Mutations in the estrogen receptor alpha hormone binding domain promote stem cell phenotype through notch activation in breast cancer cell lines 12
Aromatase Inhibitor Resistance in Breast Cancer: a Potential Role for Inflammation 12
Novel insights into the antagonistic effects of losartan against angiotensin ii/agtr1 signaling in glioblastoma cells 11
Phosphodiesterase 5 (PDE5) Expression and Function in Breast Cancer Stroma: an Attractive Opportunity for Targeted Therapy 11
Mammary Epithelium-Specific Conditional Expression of Human Mutant Ki-Ras in Mice Generates Estrogen Receptor Alpha (ER)-Positive Mammary Adenocarcinomas 11
Leptin Modulates Exosome Biogenesis in Breast Cancer Cells: an Additional Mechanism in Cell-to-Cell Communication 11
Adipocyte-derived extracellular vesicles promote breast cancer cell malignancy through HIF-1α activity 11
Farnesoid X Receptor Activation Induces Apoptosis and Inhibits Leydig Xenograft Tumor Growth 10
A new role of anandamide in human sperm: focus on metabolism. 10
Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells. 10
A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells 10
Activated Farnesoid X Receptor Inhibits Growth of Tamoxifen-Resistant MCF-7 Breast Cancer Cells, through down-Regulation of HER2 Expression. 10
. Estradiol via estrogen receptor beta influences ROS levels through the transcriptional regulation of SIRT3 in human seminoma TCam-2 cells 9
Activated Farnesoid X Receptor inhibits growth of tamoxifen-resistant breast cancer cells. 9
Conditional expression of Ki-RasG12V in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 9
Leptin Increases HER2 Stability through HSP90 in Breast Cancer Cells. 9
Role of Phosphodiesterase 5 (PDE5) in Breast Cancer Stroma: Implications for Targeted Therapy 9
Activated FXR Inhibits Leptin Signaling and Counteracts Tumor-promoting Activities of Cancer-Associated Fibroblasts in Breast Malignancy 9
Phosphodiesterase 5 (PDE5) is highly expressed in cancer-associated fibroblasts and enhances breast tumor progression 9
Conditional expression of Ki-Ras(G12V) in the mammary epithelium of transgenic mice induces estrogen receptor alpha (ERα)-positive adenocarcinoma 9
Conventional progesterone receptors (PR) B and PRA are expressed in human spermatozoa and may be involved in the pathophysiology of varicocoele: a role for progesterone in metabolism. 9
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 8
Activated-farnesoid X receptor (FXR) expressed in human sperm alters its fertilising ability 8
Farnesoid X Receptor ligand CDCA inhibits growth of tamoxifen-resistant breast cancer cells 8
Estrogen receptor beta (ERβ) produces autophagy and necroptosis in human seminoma cell line through the binding of the Sp1 on the phosphatase and tensin homolog deleted from chromosome 10 (PTEN) promoter gene 8
FXR ligands, by interfering with tumor/microenvironment crosstalk, inhibit breast tumor growth and progression 8
A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells 8
. May tumor microenvironment cooperate with a mutant ERα to promote breast cancer progression? 7
A novel leptin antagonist peptide inhibits breast cancer growth in vitro and in vivo 7
Leptin as a mediator of tumor-stromal interactions promotes breast cancer stem cell activity. 7
Glucocorticoid Receptor as a Potential Target to Decrease Aromatase Expression and Inhibit Leydig Tumor Growth 5
Inhibition of Leydig tumor growth by farnesoid X receptor activation: the in vitro and in vivo basis for a novel therapeutic strategy 5
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 5
The transcriptional coregulator PGC-1β controls mitochondrial function and anti-oxidant defence in skeletal muscles. 5
Leptin increases HER2 protein levels through a STAT3-mediated up-regulation of Hsp90 in breast cancer cells 4
Mechanisms of divergent effects of activated peroxisome proliferator-activated receptor-γ on mitochondrial citrate carrier expression in 3T3-L1 fibroblasts and mature adipocytes 4
Leptin mediates tumor-stromal interactions that promote the invasive growth of breast cancer cells. 4
Farnesoid X receptor inhibits tamoxifen-resistant MCF-7 breast cancer cell growth through downregulation of HER2 expression. 4
Human Sperm Express the Receptor for Glucagon-like Peptide-1 (GLP-1), Which Affects Sperm Function and Metabolism 3
Nandrolone and stanozolol upregulate aromatase expression and further increase IGF-I-dependent effects on MCF-7 breast cancer cell proliferation 3
Recombinant Arabidopsis HSP70 Sustains Cell Survival and Metastatic Potential of Breast Cancer Cells. 3
Human sperm physiology: estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ) influence sperm metabolism and may be involved in the pathophysiology of varicocele-associated male infertility. 3
Human sperm anatomy and endocrinology in varicocele: role of androgen receptor 3
T3 enhances thyroid cancer cell proliferation through TRβ1/Oct-1-mediated cyclin D1 activation 3
Farnesoid X receptor, through the binding with steroidogenic factor 1-responsive element, inhibits aromatase expression in tumor Leydig cells. 3
Recombinant Arabidopsis HSP70 sustains cell survival and metastatic potential of breast cancer cells 3
Tamoxifen through GPER upregulates aromatase expression: a novel mechanism sustaining tamoxifen-resistant breast cancer cell growth 2
Synthesis and anti-proliferative activity of a small library of 7-substituted 5H-pyrrole [1,2-a][3,1]benzoxazin-5-one derivatives 2
Totale 416
Categoria #
all - tutte 5.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2022/20233 2 0 0 0 0 0 1 0 0 0 0 0
2023/20243 1 1 0 0 0 1 0 0 0 0 0 0
2024/2025365 2 1 0 0 0 90 40 11 31 0 48 142
2025/202645 45 0 0 0 0 0 0 0 0 0 0 0
Totale 416